GWN Securities Inc. Purchases New Stake in The Clorox Company (NYSE:CLX)

GWN Securities Inc. acquired a new stake in The Clorox Company (NYSE:CLX - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 10,753 shares of the company's stock, valued at approximately $1,712,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CLX. Mizuho Securities USA LLC lifted its stake in shares of Clorox by 46,877.8% in the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company's stock valued at $733,095,000 after buying an additional 4,490,421 shares during the period. Ilex Capital Partners UK LLP lifted its position in shares of Clorox by 512.7% in the 3rd quarter. Ilex Capital Partners UK LLP now owns 542,110 shares of the company's stock worth $88,315,000 after acquiring an additional 453,624 shares during the period. Amundi grew its holdings in shares of Clorox by 42.6% during the 4th quarter. Amundi now owns 1,032,283 shares of the company's stock worth $165,816,000 after purchasing an additional 308,234 shares in the last quarter. Assenagon Asset Management S.A. increased its position in shares of Clorox by 302.0% during the fourth quarter. Assenagon Asset Management S.A. now owns 353,367 shares of the company's stock valued at $57,390,000 after purchasing an additional 265,455 shares during the period. Finally, State Street Corp increased its position in shares of Clorox by 3.1% during the third quarter. State Street Corp now owns 8,182,109 shares of the company's stock valued at $1,332,947,000 after purchasing an additional 245,525 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Clorox Price Performance

Clorox stock traded up $0.30 on Thursday, reaching $145.46. The company's stock had a trading volume of 1,257,827 shares, compared to its average volume of 1,214,898. The business's fifty day moving average price is $153.40 and its 200 day moving average price is $159.97. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The company has a market cap of $17.92 billion, a price-to-earnings ratio of 39.74, a PEG ratio of 2.62 and a beta of 0.45. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the prior year, the business posted $2.16 EPS. Equities analysts expect that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be paid a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.35%. Clorox's dividend payout ratio (DPR) is currently 133.33%.

Analysts Set New Price Targets

A number of research firms have weighed in on CLX. Barclays lifted their price target on shares of Clorox from $130.00 to $140.00 and gave the stock an "underweight" rating in a research note on Wednesday, February 5th. Royal Bank of Canada reiterated a "sector perform" rating and set a $150.00 target price on shares of Clorox in a research report on Thursday, January 30th. DA Davidson dropped their price target on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a research report on Wednesday, February 5th. StockNews.com cut shares of Clorox from a "buy" rating to a "hold" rating in a research note on Sunday, January 5th. Finally, Evercore ISI upped their price objective on Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Three investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $159.62.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.